Her er du: Hjem » Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy? » Pub MED artikler » Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?

Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?

Acta Oncol. 2019
58(sup1):S42-S48. doi: 10.1080/0284186X.2018.1540885.
Epub 2018 Dec 7.

Blood-based, cancer-associated biomarkers may detect subjects at risk of having neoplastic diseases. The aim of the present study was to evaluate whether elevated serological protein biomarker levels may identify adenoma patients, who are at increased risk of being diagnosed with subsequent primary malignancy.

Forfattere: Piper TB, Jørgensen LN, Olsen J, Nielsen KT, Davis G, Johansen JS, Jarle Christensen I, Nielsen HJ

Se på Pub MED

Print Friendly, PDF & Email

Donation / Partnerskab

Er du interesseret i at donere til vores forskning som privatperson, virksomhed eller forening?

Dit navn *

Din e-mail *

Dit tlf. nummer

Din besked *

  Emne

Kontaktoplysninger

ColoRectal Cancer Research

Gastroenheden, Hvidovre Hospital

Kettegård Allé 30

2650 Hvidovre

Email: info@colorectalcancer.dk